Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey
Jufang Shi(Shanghai Jiao Tong University), Min Dai(Nanfang Hospital), Zhouguang Hui(Chinese Academy of Medical Sciences & Peking Union Medical College), Debin Wang(Anhui Medical University), Jin‐Hu Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Yang(Guangxi Medical University), Huiyao Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Puyuan Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaojing Xing(Liaoning Cancer Hospital & Institute), Shangmei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Junling Li(Tianjin Academy of Agricultural Sciences), Xianzhen Liao(Hunan Cancer Hospital), Jiansong Ren(Chinese Academy of Medical Sciences & Peking Union Medical College), Kai Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Le Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning Li(Nanjing University of Chinese Medicine), Chengcheng Liu(Zhejiang University), Ye Zhang(University of Electronic Science and Technology of China), Jie He(First Affiliated Hospital of Jinan University), Yunchao Huang(North China University of Water Resources and Electric Power), Ning Wu(Regeneron (United States)), Boyan Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongzhen Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wendong Lei(Chinese Academy of Medical Sciences & Peking Union Medical College), Juan Zhu(Guangdong Province Women and Children Hospital), Yuqin Liu(Qingdao University), Lingbin Du(Shandong University)
Cited by 134
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k